Investing Profile

Prem Tumkosit

VCInvestor
Managing Director at Merck Global Health Innovation Fund (Merck & Co)
msdghifund.comNew York City
Photo of Prem Tumkosit, Managing Director at Merck Global Health Innovation Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
Unnatural Products
Series BMar 2026$45M
Series ADec 2023$32M
$83M
Co-investors: Ameena El-Bibany (Artis Ventures (AV)), Vasudev Bailey (Artis Ventures (AV)), Nicholas Shekerdemian (The Venture Collective (TVC))
Ash
Series AOct 2024$10M
$16M
Co-investors: Brandon Hoffman (Sunset Ventures), Kevin Alvarez-Fung (Predictive VC), Diana Melencio (XRC Ventures), David Yakobovitch (DataPower Ventures), Sreeraman M G
Pragma Bio
Series AMar 2023$10M
$15M
Co-investors: Nicholas Shekerdemian (The Venture Collective (TVC)), Milad Alucozai (Entrepreneur First)
Absci
Corporate RoundFeb 2021
$70M
Co-investors: Eli Casdin (Casdin Capital)
Zapata Quantum
Series BNov 2020$38M
$82M
Co-investors: Gil Beyda (Comcast Ventures), Jeff Huber (Triatomic Capital), Ayal Itzkovitz (Pitango Venture Capital), Russ Wilcox (Pillar VC), Markus Solibieda (BASF Venture Capital), Alice Newcombe-Ellis (Ahren Innovation Capital)
Strata Oncology
Series BMay 2018$26M
$26M